Selumetinib Synthesis via Protected Intermediate and Deprotection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for the synthesis of selumetinib and its acid addition salts are inefficient and lack a convenient process.
Innovation Solution
A novel process involving the reaction of compound Va with compound IV, followed by deprotection of compound IIIa to obtain selumetinib, and optional acid addition to form selumetinib acid salts, utilizing various coupling agents, acids, and bases to achieve efficient synthesis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If existing methods are used for synthesis of selumetinib, then the process is established, but the synthesis is inefficient and lacks convenience
Solution Approach 1:
The synthesis process is divided into distinct modular steps: Step 1 prepares compound Va from starting materials, Step 2 couples compound Va with compound IV to form intermediate IIIa, and Step 3 deprotects IIIa to yield selumetinib. Each step uses optimized conditions and can be independently controlled, improving overall efficiency and convenience of manufacture.
Solution Approach 2:
Compound Va is prepared in advance with a protected hydroxyl group that can be deprotected later. This preliminary preparation allows the coupling reaction to proceed efficiently without worrying about hydroxyl group interference, and the final deprotection step conveniently releases the active selumetinib product.
2Manufacturing precision
If existing synthesis methods are used, then the process is known, but yield and purity are not optimized
Solution Approach 1:
The synthesis employs specific parameter optimizations including: using EDC·HCl and HOBt as coupling agents in DMF solvent at controlled temperatures, employing specific acid combinations for deprotection, and optimizing reaction times. These parameter changes achieve both high yield (>80% in key steps) and high purity products.
Solution Approach 2:
Compound IIIa serves as a stable intermediate with a protected hydroxyl group that facilitates the synthesis. The protecting group acts as an intermediary that prevents side reactions during coupling, then is cleanly removed to give high-purity selumetinib, improving both yield and manufacturing precision.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Provides a convenient and efficient method for the preparation of selumetinib and its acid addition salts, ensuring high yield and purity.
Implementation Method 1
reacting a compound of formula Va with a compound of formula IV to obtain a compound of formula IIIa
Implementation Method 2
deprotecting the compound IIIa to obtain selumetinib
Data Source
AI summary
The present invention is related to a process of selumetinib, a compound of formula II, or an acid addition salt thereof. The present invention is also related to an intermediate compound of formula III or a salt or a hydrate thereof, and its use thereof in the preparation of selumetinib, or an acid addition salt thereof. The present invention is further related to a process for the preparation of an intermediate compound of formula